Technologies Munich News Today

Bruce Power is doubling its capacity to produce its cancer-fighting medical isotopes. In partnership with Saug...

A second isotope production line is being installed at Bruce 7 to double its production capacity to meet forecast increases in demand. Bruce Power and Saugeen Ojibway Nation have also announced an expansion of their partnership for the production of and marketing of medical radioisotopes.

PORTLAND, Ore., May 29, 2024 /PRNewswire/ -- Allied Market Research published a report, titled, "Radiopharmaceuticals Market by End User (Hospitals and Clinics, Medical Imaging Centers, and

Bruce Power is doubling its capacity to produce its cancer-fighting medical isotopes. In partnership with Saugeen Ojibway Nation, Isogen, and ITM Isot...

License will support ITM’s efforts in preparing for the commercialization of its diagnostic and therapeutic radiopharmaceutical pipeline across the U.S.

Garching / Munich, Germany, January 16, 2024 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced the...

Receipt of Radioactive Material Handling License (RAM License) for production of n.c.a. Lutetium-177Progress demonstrates company’s ability to rapidly increase GMP manufacturing capabilities to further supply growing demand for radiopharmaceuticals

Receipt of Radioactive Material Handling License (RAM License) for production of n.c.a. Lutetium-177Progress demonstrates company’s ability to rapidly increase GMP manufacturing capabilities to further supply growing demand for radiopharmaceuticals

Receipt of Radioactive Material Handling License (RAM License) for production of n.c.a. Lutetium-177Progress demonstrates company’s ability to rapidly...

Garching / Munich, Germany, December 21, 2023 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that CEO, Steffen Schuster and CFO, Dr. Klaus Maleck